FDA Drug Application (022048) for TRIESENCE by ALCON

Back to FDA Applications sponsored by ALCON

Application Number022048
Product Number001
FormINJECTABLE;INTRAVITREAL
Dosage40MG/ML (40MG/ML)
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameTRIESENCE
Active IngredientTRIAMCINOLONE ACETONIDE



Back to FDA Applications sponsored by ALCON

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.